The Effect of SGLT2 Inhibitor Therapy on Endothelial Progenitor Cell Function in Patients With Heart Failure

*Cardiology Department, Assuta Ashdod Medical Center, Ashdod, Israel;

†Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel;

‡Hematology Laboratory, Assuta Ashdod Medical Center, Ashdod, Israel; and

§Biochemistry Laboratory, Assuta Ashdod Medical Center, Ashdod, Israel.

Correspondence: Yana Kakzanov, MD, Cardiology Department, Assuta Ashdod Hospital, 7 Harefua St, Ashdod, Israel, 7747629 (e-mail: [email protected]).

Supported by the Assuta Ashdod research program.

The authors report no conflicts of interest.

Y. Kakzanov designed the research, enrolled patients, interpreted the results, and drafted the manuscript. Z. Sevilya designed the research, performed the experiments, acquired the data, performed the statistical analysis, and drafted the manuscript. A. Goldman designed the research and enrolled patients. M. Cipok and V. Hershkovitz performed the experiments and acquired the data. E. I. Lev designed and oversaw the research, analyzed and interpreted the data, and revised the final version of the manuscript. All authors have read and approved the final manuscript.

Comments (0)

No login
gif